These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 29726685)

  • 1. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
    Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy.
    Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment.
    Wang D; Huang Y; Yuan J; Wang S; Sheng J; Zhao Y; Zhang H; Wang X; Yu Y; Shi X; He Z; Liu T; Sun B; Sun J
    J Control Release; 2024 Nov; 375():47-59. PubMed ID: 39222794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine.
    Luo C; Sun J; Sun B; Liu D; Miao L; Goodwin TJ; Huang L; He Z
    Small; 2016 Dec; 12(46):6353-6362. PubMed ID: 27689847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Paclitaxel Prodrug Nanoparticles via Redox-Activatable Linkage and Effective Carriers for Enhanced Chemotherapy.
    Lu S; Xia R; Wang J; Pei Q; Xie Z; Jing X
    ACS Appl Mater Interfaces; 2021 Oct; 13(39):46291-46302. PubMed ID: 34558902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.
    Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z
    Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety.
    Sun Y; Wang S; Li Y; Wang D; Zhang Y; Zhang H; Lei H; Liu X; Sun J; Sun B; He Z
    Acta Biomater; 2023 Feb; 157():417-427. PubMed ID: 36513247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
    Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
    Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the Role of Connecting Bonds and Modifying Chains in the Rational Design of Prodrug Nanoassemblies.
    Wang D; Du C; Wang S; Li L; Liu T; Song J; He Z; Zhai Y; Sun B; Sun J
    ACS Appl Mater Interfaces; 2022 Nov; 14(45):51200-51211. PubMed ID: 36397309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic study of the covalent loading of paclitaxel via disulfide linkers for controlled drug release.
    Yuan L; Chen W; Hu J; Zhang JZ; Yang D
    Langmuir; 2013 Jan; 29(2):734-43. PubMed ID: 23252889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity.
    Yang Y; Sun B; Zuo S; Li X; Zhou S; Li L; Luo C; Liu H; Cheng M; Wang Y; Wang S; He Z; Sun J
    Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
    Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
    J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of paclitaxel and doxorubicin using mixed micelles based on the redox sensitive prodrugs.
    Yang M; Ding H; Zhu Y; Ge Y; Li L
    Colloids Surf B Biointerfaces; 2019 Mar; 175():126-135. PubMed ID: 30529818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy.
    Ma X; Özliseli E; Zhang Y; Pan G; Wang D; Zhang H
    Biomater Sci; 2019 Jan; 7(2):634-644. PubMed ID: 30534690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational Design of Redox-Responsive and P-gp-Inhibitory Lipid Nanoparticles with High Entrapment of Paclitaxel for Tumor Therapy.
    Chen SQ; Wang C; Tao S; Wang YX; Hu FQ; Yuan H
    Adv Healthc Mater; 2018 Sep; 7(17):e1800485. PubMed ID: 29995353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment.
    Liu T; Li L; Wang S; Dong F; Zuo S; Song J; Wang X; Lu Q; Wang H; Zhang H; Cheng M; Liu X; He Z; Sun B; Sun J
    Nat Commun; 2022 Nov; 13(1):7228. PubMed ID: 36434014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities.
    Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J
    Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.